|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/00 | |
| A61K 31/138 | |||
| A61P 25/28 |
| (11) | Number of the document | 1458368 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02789574.7 |
| Date of filing the European patent application | 2002-11-27 | |
| (97) | Date of publication of the European application | 2004-09-22 |
| (45) | Date of publication and mention of the grant of the patent | 2007-11-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2002/036132 |
| Date | 2002-11-27 |
| (87) | Number | WO 2003/049724 |
| Date | 2003-06-19 |
| (30) | Number | Date | Country code |
| 339174 P | 2001-12-11 | US |
| (72) |
BYMASTER, Franklin, Porter, US
GEHLERT, Donald, Richard, US
MCKINZIE, David, Lee, US
YANG, Charles, Renkin, US
|
| (73) |
ELI LILLY AND COMPANY,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | USE OF NOREPINEPHRINE REUPTAKE INHIBITORS FOR THE TREATMENT OF COGNITIVE FAILURE |
| USE OF NOREPINEPHRINE REUPTAKE INHIBITORS FOR THE TREATMENT OF COGNITIVE FAILURE |